• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围手术期疼痛管理包的成本效益:基于注册的研究。

Cost-effectiveness of the Perioperative Pain Management Bundle a registry-based study.

机构信息

Department of Anesthesiology and Intensive Care, University Hospital Medical Centre "Dr. Dragisa Misovic - Dedinje", Belgrade, Serbia.

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

出版信息

Front Public Health. 2023 Sep 7;11:1157484. doi: 10.3389/fpubh.2023.1157484. eCollection 2023.

DOI:10.3389/fpubh.2023.1157484
PMID:37744520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10513912/
Abstract

INTRODUCTION

The Perioperative Pain Management Bundle was introduced in 10 Serbian PAIN OUT network hospitals to improve the quality of postoperative pain management. The Bundle consists of 4 elements: informing patients about postoperative pain treatment options; administering a full daily dose of 1-2 non-opioid analgesics; administering regional blocks and/or surgical wound infiltration; and assessing pain after surgery. In this study, we aimed to assess the cost-effectiveness of the Bundle during the initial 24 h after surgery.

MATERIALS AND METHODS

The assessment of cost-effectiveness was carried out by comparing patients before and after Bundle implementation and by comparing patients who received all Bundle elements to those with no Bundle element. Costs of postoperative pain management included costs of the analgesic medications, costs of labor for administering these medications, and related disposable materials. A multidimensional Pain Composite Score (PCS), the effectiveness measurement, was obtained by averaging variables from the International Pain Outcomes questionnaire evaluating pain intensity, interference of pain with activities and emotions, and side effects of analgesic medications. The incremental cost-effectiveness ratio (ICER) was calculated as the incremental change in costs divided by the incremental change in PCS and plotted on the cost-effectiveness plane along with the economic preference analysis.

RESULTS

The ICER value calculated when comparing patients before and after Bundle implementation was 181.89 RSD (1.55 EUR) with plotted ICERs located in the northeast and southeast quadrants of the cost-effectiveness plane. However, when comparing patients with no Bundle elements and those with all four Bundle elements, the calculated ICER was -800.63 RSD (-6.82 EUR) with plotted ICERs located in the southeast quadrant of the cost-effectiveness plane. ICER values differ across surgical disciplines.

CONCLUSION

The proposed perioperative pain management Bundle is cost-effective. The cost-effectiveness varies depending on the number of implemented Bundle elements and fluctuates across surgical disciplines.

摘要

引言

围手术期疼痛管理包在 10 家塞尔维亚 PAIN OUT 网络医院推出,以提高术后疼痛管理质量。该包由 4 个元素组成:告知患者术后疼痛治疗选择;给予每日 1-2 次全剂量非阿片类镇痛药;给予区域阻滞和/或手术切口浸润;以及术后评估疼痛。在这项研究中,我们旨在评估术后 24 小时内该包的成本效益。

材料和方法

成本效益评估是通过比较实施包前后的患者以及接受所有包元素的患者与没有包元素的患者来进行的。术后疼痛管理的成本包括镇痛药的成本、给予这些药物的劳动力成本以及相关的一次性材料成本。多维疼痛综合评分(PCS)是通过平均国际疼痛结局问卷中评估疼痛强度、疼痛对活动和情绪的干扰以及镇痛药副作用的变量来获得的。增量成本效益比(ICER)是通过将成本的增量变化除以 PCS 的增量变化计算得出的,并与经济偏好分析一起绘制在成本效益平面上。

结果

当比较实施包前后的患者时,计算出的 ICER 值为 181.89 塞尔维亚第纳尔(1.55 欧元),绘制的 ICER 位于成本效益平面的东北和东南象限。然而,当比较没有包元素的患者和有所有四个包元素的患者时,计算出的 ICER 为-800.63 塞尔维亚第纳尔(-6.82 欧元),绘制的 ICER 位于成本效益平面的东南象限。ICER 值因手术学科而异。

结论

拟议的围手术期疼痛管理包具有成本效益。成本效益取决于实施的包元素数量,并在手术学科之间波动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ac/10513912/b222d71c1265/fpubh-11-1157484-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ac/10513912/b222d71c1265/fpubh-11-1157484-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ac/10513912/b222d71c1265/fpubh-11-1157484-g001.jpg

相似文献

1
Cost-effectiveness of the Perioperative Pain Management Bundle a registry-based study.围手术期疼痛管理包的成本效益:基于注册的研究。
Front Public Health. 2023 Sep 7;11:1157484. doi: 10.3389/fpubh.2023.1157484. eCollection 2023.
2
The Perioperative Pain Management Bundle is Feasible: Findings From the PAIN OUT Registry.围手术期疼痛管理包是可行的:来自 PAIN OUT 登记处的发现。
Clin J Pain. 2023 Oct 1;39(10):537-545. doi: 10.1097/AJP.0000000000001153.
3
Implementing a thermal care bundle for inadvertent perioperative hypothermia: A cost-effectiveness analysis.实施意外围手术期低体温护理包:成本效益分析。
Int J Nurs Stud. 2019 Sep;97:21-27. doi: 10.1016/j.ijnurstu.2019.04.017. Epub 2019 May 4.
4
A cost-effectiveness analysis of parecoxib in the management of postoperative pain in the Greek health care setting.帕瑞昔布用于希腊医疗保健环境中术后疼痛管理的成本效果分析。
Clin Ther. 2013 Aug;35(8):1118-24. doi: 10.1016/j.clinthera.2013.06.004. Epub 2013 Jul 16.
5
A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.非 PCOS 女性体外受精中仅冷冻或新鲜胚胎移植的成本效益分析。
Hum Reprod. 2018 Oct 1;33(10):1907-1914. doi: 10.1093/humrep/dey253.
6
A cost-utility and cost-effectiveness analysis of an acute pain service.一项急性疼痛服务的成本效用和成本效益分析。
J Clin Anesth. 2004 May;16(3):159-67. doi: 10.1016/j.jclinane.2003.06.002.
7
Patient-Controlled Intravenous Morphine Analgesia Combined with Transcranial Direct Current Stimulation for Post-Thoracotomy Pain: A Cost-Effectiveness Study and A Feasibility For Its Future Implementation.患者自控静脉注射吗啡镇痛联合经颅直流电刺激用于开胸术后疼痛:成本效益研究及其未来实施的可行性。
Int J Environ Res Public Health. 2020 Jan 28;17(3):816. doi: 10.3390/ijerph17030816.
8
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
9
10
Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy.意大利术后疼痛管理中镇痛治疗的作业成本法分析。
Minerva Med. 2016 Feb;107(1):1-13.

引用本文的文献

1
The AI and Automation in Anaesthesia (TRIPLE-A) Perioperative Database in Eastern Denmark 2017-: A Platform for Epidemiology, AI-Driven Prediction, Quality Control and Automated Data Retrieval.丹麦东部麻醉领域的人工智能与自动化(TRIPLE - A)围手术期数据库(2017年至今):一个用于流行病学、人工智能驱动预测、质量控制和自动数据检索的平台。
Acta Anaesthesiol Scand. 2025 Oct;69(9):e70116. doi: 10.1111/aas.70116.

本文引用的文献

1
The Perioperative Pain Management Bundle is Feasible: Findings From the PAIN OUT Registry.围手术期疼痛管理包是可行的:来自 PAIN OUT 登记处的发现。
Clin J Pain. 2023 Oct 1;39(10):537-545. doi: 10.1097/AJP.0000000000001153.
2
Following Evidence-Based Recommendations for Perioperative Pain Management after Cesarean Section Is Associated with Better Pain-Related Outcomes: Analysis of Registry Data.遵循剖宫产术后围手术期疼痛管理的循证建议与更好的疼痛相关结局相关:登记数据分析
J Clin Med. 2023 Jan 14;12(2):676. doi: 10.3390/jcm12020676.
3
A novel methodology to integrate outcomes regarding perioperative pain experience into a composite score: Prediction model development and validation.
一种将围手术期疼痛体验相关结局整合到综合评分中的新方法:预测模型的建立和验证。
Eur J Pain. 2022 Nov;26(10):2188-2197. doi: 10.1002/ejp.2033. Epub 2022 Sep 17.
4
Finding the vulnerable postoperative population: A two-step cluster analysis of the PAIN-OUT registry.确定易受影响的术后人群:PAIN-OUT 登记处的两步聚类分析。
Eur J Pain. 2022 Sep;26(8):1732-1745. doi: 10.1002/ejp.1997. Epub 2022 Jul 7.
5
Efficacy of Liposomal Bupivacaine and Bupivacaine Hydrochloride vs Bupivacaine Hydrochloride Alone as a Periarticular Anesthetic for Patients Undergoing Knee Replacement: A Randomized Clinical Trial.局部麻醉药盐酸布比卡因脂质体与盐酸布比卡因对比用于膝关节置换术患者关节周围麻醉的疗效:一项随机临床试验。
JAMA Surg. 2022 Jun 1;157(6):481-489. doi: 10.1001/jamasurg.2022.0713.
6
Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021.执行摘要:拯救脓毒症运动:2021年脓毒症和脓毒性休克管理国际指南。
Crit Care Med. 2021 Nov 1;49(11):1974-1982. doi: 10.1097/CCM.0000000000005357.
7
Cost-effectiveness of tapentadol immediate release versus oxycodone immediate release for acute post-operative pain after major hip surgeries.曲马多速释片与盐酸羟考酮速释片治疗髋部大手术后急性术后疼痛的成本效果分析。
Curr Med Res Opin. 2022 Jan;38(1):115-121. doi: 10.1080/03007995.2021.1993161. Epub 2021 Oct 23.
8
Cost-effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain.奥列西定治疗急性疼痛的成本效益和成本效益分析。
J Comp Eff Res. 2021 Oct;10(15):1107-1119. doi: 10.2217/cer-2021-0107. Epub 2021 Jul 9.
9
Patient-Controlled Analgesia (PCA): Intravenous Administration (IV-PCA) versus Oral Administration (Oral-PCA) by Using a Novel Device (PCoA® Acute) for Hospitalized Patients with Acute Postoperative Pain-A Comparative Retrospective Study.患者自控镇痛(PCA):使用新型装置(PCoA® Acute)对住院急性术后疼痛患者进行静脉给药(IV-PCA)与口服给药(Oral-PCA)的比较回顾性研究。
Pain Res Manag. 2021 May 4;2021:2542010. doi: 10.1155/2021/2542010. eCollection 2021.
10
'Desire for more analgesic treatment': pain and patient-reported outcome after paediatric tonsillectomy and appendectomy.“对更多镇痛治疗的渴望”:小儿扁桃体切除术和阑尾切除术的疼痛和患者报告结局。
Br J Anaesth. 2021 Jun;126(6):1182-1191. doi: 10.1016/j.bja.2020.12.047. Epub 2021 Mar 5.